OUP user menu

Cardio NewsWire

Please click here to view the archive of previous Cardio NewsWire stories. Each item is removed from the archive after 90 days. 

Isabel Bardinet receives PCMA Chairman’s Award

The Heart Failure Association Declaration

A new heart failure cardiologist is set to conquer Europe

Thrombus aspiration does not improve 12-month outcomes

ESC Grants now available

EU Research Funding

18th International Congress on Advances in Cardiac Ultrasound

ESC Training Grants for 2016

 

European Society of Cardiology CEO wins PCMA Chairman’s Award

The Chief Executive Officer of the European Society of Cardiology (ESC), Isabel Bardinet, has received the 2015 Professional Convention Management Association (PCMA) Chairman’s Award. It was presented 14 January 2016 at the PCMA Convening Leaders conference in Vancouver, Canada.

The award is the highest honour bestowed by the Chairman of the PCMA.

Isabel Bardinet was acknowledged for her creative involvement of the community in advancing the ESC’s mission at ESC Congress 2015. ESC staff teamed up with local partners to create the London Heart Trail, an interactive walk along London’s iconic South Bank with a specific aim of promoting awareness of heart health to the London public.

ESC Congress, the ESC’s annual event, is the world’s largest and most influential cardiovascular meeting. In 2015 the five-day conference attracted 34,000 delegates to ExCeL London.

Isabel Bardinet said: “Recognition from PCMA, who is a standard setter for our profession, means an awful lot to us.”

“The ESC’s mission is to reduce the burden of cardiovascular disease in Europe. This burden affects nearly one person in four worldwide and kills over four million people in Europe alone every year. Education, sharing and dissemination are our main tools to deal with this pandemic. The most visible of our activities is ESC Congress.”

“The Heart Trail was organised and implemented for the people in London during the congress to get the messages of prevention across to them and indirectly thereby save lives. The success of the Heart Trail was mostly thanks to London & Partners and ExCeL, without whom this would never have been possible.”

“On behalf of the London Team – that is to say London & Partners, ExCeL, ESC staff and volunteers – I would like to thank PCMA for such a wonderful reward which means so much to us all.”

James Rees, Executive Director at ExCeL London, said: “On behalf of ExCeL London, I would like to congratulate Isabel Bardinet on winning the PCMA Chairman’s Award. This is hugely-deserved recognition and we are thrilled for her and the ESC team. Isabel is a thought-leader in our industry who recognises, and champions, the role of events to support the missions of medical associations and leave a legacy of positive change in the destinations they select. It was a pleasure for us to work with ESC and London as a whole during 2015 to host the ESC Congress and raise awareness of the healthy changes that can be made to reduce the burden of cardiovascular disease across London and the UK.”

 

The Heart Failure Association Declaration

Participants of the 5th National Heart Failure Societies’ Presidents’ Summit.

The 5th National Heart Failure Societies’ Presidents’ Summit, organized by the Heart Failure Association, was held on 24 October, 2015 in Ljubljana, Slovenia. Representatives from 36 countries, the members of the Heart Failure Association Board, and members of the National Heart Failure Societies Committee discussed topics of key relevance for global management and better organization of care in the field of heart failure.

They specifically addressed the continuous education and heart failure sub-specialization curriculum with accreditation process, importance of epidemiological and management information from registries, and the challenges how to put the patient and self-care in the spotlight of comprehensive heart failure management.

The emerging role of young heart failure specialists – the HoT project – was presented to the national representatives, with an initiative to have active representatives from all ESC member countries. Finally, the latest activities of the Global Heart Failure Awareness Program campaign were presented; this project aims to reach out to all stakeholders in the worldwide heart failure community to improve understanding and recognition of the condition and to align intervention strategies.

To foster this campaign, the Heart Failure Association Declaration and A Call for Action was adopted and signed by all participants. This document emphasizes the importance of the campaign and genuine dedication to implementation in the respective countries.

 

A new heart failure cardiologist is set to conquer Europe

The declaration of war on heart failure (HF) by the iconic Eugene Braunwald MD, marked the spectacular culmination of the first Post Graduate Course on Heart Failure (PCHF) in October 2015.

After 160 hours of intense lectures, 140 hours of self-study and 8 elaborate examinations, Europe witnessed the graduation of the first genuine HF cardiologists trained on its soil. The first group consisted of 59 participants from 32 countries including participants from India, Mexico and the Dominican Republic.

The course was designed and organized by the department cardiology at the University Hospital Zurich, led by the energetic and captivating chairs Prof. Frank Ruschitzka, Prof. Thomas F. Lüscher and Dr. Ruth Amstein. The impressive network of the course directors allowed for lectures given by key opinion leaders from around the world and encouraged interactive discussions with the participants.

The course was also highly dynamic, as the structure was continuously adjusted to allow implementation of paradigm shifting scientific discoveries as they occurred. For instance, the lead author of the PARADIGM study Prof. John McMurray presented unique and detailed insights into the study just weeks after its publication.

In addition to lectures, there were live cases from the catheterization lab, hands on training in various skills including echocardiography, LVAD trouble shooting and ECMO implantation, with clinical rounds and interesting HF cases presented by the participants. The themes were carefully selected to include all relevant aspects of contemporary HF care, including a module with hands on training in device implantation and troubleshooting.

The quality of the course is underscored by the fact that it was categorised as excellent by more than 80% of the candidates. In summary, PCHF is a truly unique initiative that will hopefully allow a swift response to the impending HF epidemic.

B. Daan Westenbrink MD PhD
Department of Cardiology,
University Medical Center Groningen,
Hanzeplein 1, 9700 RB Groningen,
The Netherlands.
b.d.westenbrink@umcg.nl

 

TATORT-NSTEMI trial shows thrombus aspiration does not improve 12-month outcomes

First randomised trial does not support routine thrombectomy in NSTEMI.

Thrombus aspiration before percutaneous coronary intervention (PCI) does not improve 12-month clinical outcomes in patients with NSTEMI, according to results from the TATORT-NSTEMI trial published 19 November in European Heart Journal: Acute Cardiovascular Care. (1)

Professor Holger Thiele, principal investigator, said: “TATORT-NSTEMI (2) was the first randomised trial investigating the impact of thrombectomy prior to PCI, compared to standard PCI, in patients with NSTEMI. All previous trials had been performed in STEMI patients.”

“Patients needed to have a visible thrombus to be included in our study, which was not the case in the STEMI trials,” added Professor Thiele. “There were good reasons to believe that thrombectomy would benefit patients with NSTEMI. Thrombus aspiration in NSTEMI is not included in guidelines because of limited data.”

TATORT-NSTEMI randomised 440 patients from eight sites in Germany in a 1:1 ratio to thrombectomy prior to PCI or standard PCI. The primary study endpoint was microvascular obstruction measured using CMR. As previously reported, thrombus aspiration added to PCI did not reduce microvascular obstruction compared to PCI alone in patients with NSTEMI (3).

The primary endpoint of the current analysis was the occurrence of major adverse cardiac events (MACE) at 12 months. MACE was defined as the composite of all-cause death, myocardial reinfarction, new congestive heart failure, and need for target vessel revascularisation. Secondary endpoints included New York Heart Association (NYHA) class and Canadian Cardiovascular Society (CCS) class, and quality of life using the standardised EuroQol5D (EQ5D) questionnaire.

Thrombectomy did not have any effect on functional class (as assessed by NYHA class and CCS class) or quality of life in patients with NSTEMI.

“Aspiration thrombectomy appears to provide no additional benefit on long-term clinical outcome for patients with NSTEMI who have had PCI,” said Professor Thiele. “This is comparable to data from the TASTE and TOTAL trials in STEMI patients which found no benefit of thrombectomy on all-cause mortality and led to the procedure being downgraded in European and American guidelines.”

ESC spokesperson Professor Steen Kristensen said: “Large trials have shown that thrombus aspiration does not work in STEMI so we no longer use it routinely, but we do use it occasionally. TATORT-NSTEMI confirms that this approach can also be applied in NSTEMI. We should think twice before we use a thrombus aspiration catheter but it might be useful in selected patients.”

References

1 Meyer-Saraei R, de Waha S, Eitel I, Desch S, Scheller B, Böhm M, Lauer B, Gawaz M, Geisler T, Gunkel O, Bruch L, Klein N, Pfeiffer D, Schuler G, Zeymer U, Thiele H. Thrombus aspiration in non-ST-elevation myocardial infarction – 12-month clinical outcome of the randomised TATORT-NSTEMI trial. Eur Heart J Acute Cardiovasc Care. DOI: 10.1177/2048872615617044

2 TATORT-NSTEMI: Thrombus Aspiration in ThrOmbus containing culprit lesions in Non-ST-Elevation Myocardial Infarction trial

3 Thiele H, de Waha S, Zeymer U, Desch S, Scheller B, Lauer B, Geisler T, Gawaz M, Gunkel O, Bruch L, Klein N, Pfeiffer D, Schuler G, Eitel I. Effect of aspiration thrombectomy on microvascular obstruction in NSTEMI patients: The TATORT-NSTEMI trial. J Am Coll Cardiol. 2014; 64: 1117–1124.

 

ESC Grants now available

 

1. EAPCI Training and Research Grants

Gain a one-year specialised training or research grant in Interventional Cardiology!

Deadline: 15 January 2016

25,000 euros to provide an opportunity for specialised research or clinical training in an ESC Member Country in the interventional cardiology field.

The European Association of Percutaneous Cardiovascular Interventions (EAPCI) offers Training and Research Grants of 25,000 Euros to provide an opportunity for specialised research or clinical training in an ESC Member Country in the interventional cardiology field.

Eligibility

  • Applicants eligible for the Research or Training Grants Programme are those who meet all the below requirements:
  • Are citizens or residents for tax purposes of a country which is a regular ESC Member or Affiliated country (see Appendix I within the Rules and Regulations)
  • Are medical graduates providing they have already proved some research potential by publishing in medical journals OR are science graduate holding a PhD or DPhil degree or equivalent or have submitted a thesis before starting the research period relating to the grant
  • Are under 36 years of age at the day of application deadline (15 January 2016) or at early stage of training (i.e. internal medicine and cardiology training completed, candidates about to enter interventional cardiology training)
  • Are members of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Join us now if you are not a member!

IMPORTANT: Applicants are not asked to identify a centre. A proposal of centre will be made by the EAPCI Training and Research Committee based on applications received from centres.

Final validation of the application will be subject to visa acceptance (when needed) as well as acceptance of the training or research centre.

Applicants who are in doubt about their eligibility are advised to contact the EAPCI prior to submitting an application.

Topic

  • Percutaneous coronary interventions with focus on metallic and bioresorbable stent technology
  • Interventional pharmacology in patients with ACS and structural heart disease
  • Transcatheter aortic valve implantation
  • Transcatheter mitral valve interventions
  • Structural heart disease interventions with focus on left atrial appendage closure, closure of PFO and atrial septal defects, paravalvular leak closure etc.
  • Intracoronary imaging (IVUS, OCT, NIRS) and physiologic lesion assessment with FFR
  • Carotid and peripheral arterial interventions

 

2. NEW: ESC early-career Training Grants

25 000 euros for a one-year training for cardiologists under 30.

Deadline: 31 January 2016

The European Society of Cardiology offers grants to help young professionals in the field of cardiology access quality training activities throughout Europe. ESC Early-Career Training Grants award young cardiologists (aged < 30 years) who wish to update their clinical training with modern cardiological methods, especially when it is impossible to learn particular techniques in their own country

Purpose of the Training Grant Programme

To provide an opportunity for clinical training in the field of cardiology in an ESC regular member country other than their own.

The goal of this award is to help young candidates attain clinical competence and acquire experience of high quality cardiological practice which will enable them to contribute to improving academic standards on return to their own country. With this goal in mind preference is given to applicants from countries or regions where modern clinical cardiology is not yet strong, provided that there is enough evidence that the applicant can, after the Training period, contribute to the improvement of clinical cardiology in his home country upon his return.

Eligibility

Any citizen or permanent resident of a country, which is a regular ESC or ESC affiliated member, can apply. Applicants who have not been ordinarily residents in such country throughout the three years preceding the application date are not eligible. Periods of residence mainly for full time education will not be accepted as ordinary residence for this purpose.

Physicians in cardiology with < 2 years in training.

Applicants should be < 30 years of age at the day of application deadline.

Tenure

Training may be undertaken for any period from six months to one year.

Level of support

Early Career Training grant recipients will receive a sum of Euros 25,000 per annum for their daily subsistence.

Application

Proposals may be submitted for specialized training or further training in the subject relevant to a particular clinical interest. Applicants are advised to seek a centre in another country within Europe which not only offers good training opportunities but is also appropriate for the particular field in which they wish to train.

Application forms, which are in electronic format, may be obtained from the ESC at the following email address:

Email: grants@escardio.org

 

3. ESC Training Grants

The European Society of Cardiology invites applications for clinical training grants.

25 000 euros for a one-year training in a European country.

Deadline: 31 January 2016

The European Society of Cardiology offers grants to help young professionals in the field of cardiology access quality training activities throughout Europe. ESC Training Grants award young cardiologists (aged < 36 years) who wish to update their clinical training with modern cardiological methods, especially when it is impossible to learn particular techniques in their own country.

For more information: grants@escardio.org

Any citizen or permanent resident of a country, which is a regular ESC or ESC Affiliated member can apply : graduates should have completed the major part of their cardiology training or have an equivalent academic grade.

Regarding the Training programme, proposals may be submitted for specialised training or further training in the subject relevant to a particular clinical interest.

Candidates are advised to seek out a centre in another country within Europe which not only offers good training opportunities but which is also appropriate for the particular field in which they wish to train.

ESC Training Grants may be held for any period from 3 months to 1 year: the recommended training period is 6 months. For invasive/ interventional techniques a 12-month period is encouraged

 

4. ESC Research Grants

A category of grants awarded to medical graduates at any stage in their career but before obtaining a "permanent", "senior staff" or "consultant" post, or for science graduates with research experience up to Junior Investigator, Lecturer, Assistant Professorship or equivalent level, whose work has been, or is, related to cardiovascular research.

25 000 euros for a one-year specialised research in a European country.

Deadline: 31 January 2016

For more information: grants@escardio.org

Applicants must be under 36 at the day of application deadline.

Any citizen or permanent resident of a country, which is a regular ESC or ESC Affiliated member, can apply. Applicants who have not been ordinarily residents in such country throughout the three years preceding the application date are not eligible. Periods of residence mainly for full time education will not be accepted as ordinary residence for this purpose.

Medical graduates can apply at any stage of their career, provided they have already proved some research potential by publishing in medical journals. Science graduates should hold a PhD or DPhil degree or equivalent or must have submitted a thesis before the grant period commences.

ESC Research Grants are awarded for a period of twelve months

 

 

New calls for EU research funding

The European Commission adopted a new work programme for 2016 -2017 on 13 October 2015, foreseeing the investment of €16 billion in research and innovation during the next two years under Horizon 2020.

Funding opportunities for health research are listed in thematic section   

 8. Health, demographic change and well-being,

which describes the overall objectives, the respective calls for proposals and the topics within each call.

The earliest calls opened on 20 October with a deadline set for 16 February 2016 or 12/13 April 2016.

Of particular interest to medicine:

Through the European Research Council (ERC), the best researchers will be able to investigate the best ideas that could lead to innovative growth-enhancing breakthroughs. Also in 2016, almost 10.000 Fellows will benefit from high -quality training and career development opportunities abroad thanks to Marie Sklodowska-Curie actions. Seven Public-Private Partnerships address strategic technologies that underpin growth and jobs in key European sectors in fields such as innovative medicine. The call on personalised m e d i c in e ( € 6 5 9 million)  will boost European industry and the so-called silver economy by investing in strategies for earlier and more effective prevention, diagnosis and treatments, and help Europe address the ageing population and chronic disease burden.

The ESC involvement in EU funded projects is under the following conditions:

1. Only projects related to the ESC mission statement and ESC strategic orientations will be considered.

2. The ESC will not participate in projects for endorsement purposes only.

Timelines and Submission Procedure

  • A project proposal synopsis should be submitted at least 12 weeks before the call’s deadline to European Affairs Staff (generic mailbox).
  • A complete project proposal should be submitted to the ESC European Affairs Committee Chair at least 6 weeks before the call’s deadline. The document should include a clear description of the expected role of the ESC & budget implications.
  • The European Affairs Committee Chair will decide whether the project proposal is complete and worthwhile to be considered by the ESC Leadership for validation.

ESC Decision

The final decision will be communicated by the European Affairs Committee Chair.

 

18th International Congress on Advances in Cardiac Ultrasound

The 18th International Congress on Advances in Cardiac Ultrasound is the third organised by course directors Dr Jeroen J Bax (Leiden, NL) left, and Dr Petros Nihoyannopoulos (London UK) right, and is held biennially to address the use of advanced clinical echocardiography (ECHO).

This unique ECHO course will focus on state of the art technology and developments in echocardiology using all technological advances to apply to daily clinical scenarios.  

One of the earliest postgraduate ECHO courses in Europe, it will take place 22-25 February 2016 in Davos, Switzerland, and is a continuation of the course that started some 36 years ago by the legendary Prof Jos RTC Roelandt. It has survived the test of time by being constantly updated to meet the rapid expansion of ECHO.

This traditional course is clinically orientated and directed towards physicians who use ECHO in their daily practice. The course will highlight the new technological developments, such as 3D echocardiography and deformation imaging. There will be a strong focus on echocardiographic solutions for common and rare clinical problems. Specifically, heart valve disease will be discussed, with emphasis on improved quantification of aortic stenosis and mitral regurgitation. Also, the application of 3D ECHO for the assessment of LV function including strain and strain rate. In addition, the pivotal clinical role of the modern echocardiographer, particularly in the emergency room and the cardiac catheterization laboratory, will be addressed.

Lectures will be delivered by international opinion leaders with specific keynote lectures on hot topics.

The memorial Jos Roelandt Lecture will be given by Prof Joseph Kislo from Duke University, NC, USA.

Highlights of the course are:

  • Strain and deformation imaging
  • Percutaneous approach for aortic and mitral valve disease
  • Quantification of severity of valve disease
  • Evaluating heart failure and preserved EF (HFPEF)
  • Echo in aortic disease
  • Cardiomyopathies, what is new?
  • Echo in emergency room
  • Advances in contrast echo
  • Stress echo in valve disease
  • Assessing complications of percutaneous interventions
  • Update on diastology
  • Focus on 3D echo
  • Focus on clinical use of echo

An important highlight is the interactive discussions between participants and faculty.

Endorsed by: European Association of Cardiovascular Imaging

Accredited by: European Board for Accreditation in Cardiology  

Online registration: www.regonline.co.uk/davos2016 and www.Livemedia.gr

The course will be live streamed and broadcast worldwide throughout the web by: www.Livemedia.com

 

 

Applications for ESC Training grants are now open

Any citizen or permanent resident of a country, which is a regular ESC or ESC Affiliated member may apply: graduates should have completed the major part of their cardiology training or have an equivalent academic grade. 

Regarding the Training programme, proposals may be submitted for specialised training or further training in the subject relevant to a particular clinical interest.

Candidates are advised to seek out a centre in another country within Europe which not only offers good training opportunities but which is also appropriate for the particular field in which they wish to train.

ESC Training Grants may be held for any period from 3 months to 1 year: the recommended training period is 6 months. For invasive/ interventional techniques a 12-month period is encouraged.

Grants are 25 000 euros for a one-year training in a European country.

Application Deadline: 31 January 2016

For more information: grants@escardio.org

 

Back to top